Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
enzalutamide tablet / Generic mfg.
NCT05406999: Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer	Recruiting	2	900	RoW	ADT, Abiraterone Acetate, Prednisolone tablets, Enzalutamide, Apalutamide, Darotamide, Rezvilutamide, PARP inhibitor, Robot-assisted radical prostatectomy	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer, Intense Endocrine Therapy	12/26	06/30